Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
europe blog main
4
×
fda
4
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
national
national top stories
new york blog main
san francisco blog main
cancer
cancer drugs
eli lilly
europe top stories
new york top stories
san francisco top stories
abbvie
accent therapeutics
acute myeloid leukemia
aducanumab
allergan
alx oncology
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
autoimmune diseases
berkeley lights
bioeurope
biogen
biohaven
biomarin pharmaceutical
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
What
new
4
×
ipo
medicines
biotech
companies
fda
research
activity
adults
allergan
approvals
approved
arrival
bio
biogen
black
cancer
clamped
class
clinic
covid
days
delays
developing
diamond
drug
economic
eluded
fast
hasn’t
hopes
including
industry
ipos
isn’t
lead
leading
life
lines
lot
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
